Care Medi

About Care Medi

CareMedi, established in 2015 by CEO Woonsup Shin, is a South Korean healthcare company specializing in wearable medical devices to improve the quality of life for individuals with diabetes. The firm is headquartered in Seoul, South Korea.

The company's core technology is an innovative electroosmosis system for precise and stable fluid control in the microliter range. This technology is the foundation for its flagship product, CareLevo®, a wearable, patch-type insulin pump. The CareLevo® is designed to be thin, lightweight (20g), and noiseless, with a 3mL (300-unit) capacity, which is 1.5 times larger than many traditional products. It enables accurate insulin infusion, with drug volumes controllable via a smartphone app, aiming for maximum user convenience and minimal disruption. The pump's low-power consumption technology allows it to deliver a 3mL volume with minimal energy, making it suitable for a wearable device.

CareMedi operates in the therapeutic devices market, with a business model focused on the development and sale of its medical devices. The company has received venture capital funding from several investors, including Company K Partners, Korea Investment Partners, AJU IB Investment, Atinum Investment, and i-SENS. It secured a Series A round in January 2022 and a later-stage venture round in November 2023, amounting to $19.3 million.